GRANULES INDIA
Quarterly Results Analysis [Dec2023]
GRANULES INDIA Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,156 Cr | ₹1,189 Cr | ₹986 Cr | ₹1,196 Cr | ₹1,146 Cr | ₹1,151 Cr | ₹1,020 Cr | ₹1,030 Cr |
Expenses | ₹905 Cr | ₹977 Cr | ₹849 Cr | ₹967 Cr | ₹915 Cr | ₹908 Cr | ₹808 Cr | ₹837 Cr |
Operating Income | ₹250 Cr | ₹213 Cr | ₹137 Cr | ₹228 Cr | ₹231 Cr | ₹243 Cr | ₹212 Cr | ₹193 Cr |
Other Income | ₹1 Cr | ₹2 Cr | ₹0 Cr | ₹3 Cr | ₹1 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr |
Interest | ₹29 Cr | ₹26 Cr | ₹22 Cr | ₹19 Cr | ₹17 Cr | ₹13 Cr | ₹7 Cr | ₹6 Cr |
Depreciation | ₹52 Cr | ₹53 Cr | ₹49 Cr | ₹49 Cr | ₹48 Cr | ₹44 Cr | ₹43 Cr | ₹40 Cr |
Profit Before Tax | ₹170 Cr | ₹136 Cr | ₹65 Cr | ₹164 Cr | ₹167 Cr | ₹190 Cr | ₹166 Cr | ₹150 Cr |
Profit After Tax | ₹126 Cr | ₹102 Cr | ₹48 Cr | ₹120 Cr | ₹124 Cr | ₹145 Cr | ₹128 Cr | ₹111 Cr |
EPS | ₹5.18 | ₹4.21 | ₹1.98 | ₹4.94 | ₹5.14 | ₹5.84 | ₹5.14 | ₹4.48 |
Industry Peers & Returns | 1W | 1M | 1Y |
GRANULES INDIA | 2.3% | -1.6% | 40.3% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
GRANULES INDIA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -2.85 % |
Y-o-Y | 0.83 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹1,156 Cr | -2.85 | |
Sep2023 | ₹1,189 Cr | 20.70 | |
Jun2023 | ₹986 Cr | -17.56 | |
Mar2023 | ₹1,196 Cr | 4.31 | |
Dec2022 | ₹1,146 Cr | -0.40 | |
Sep2022 | ₹1,151 Cr | 12.87 | |
Jun2022 | ₹1,020 Cr | -1.01 | |
Mar2022 | ₹1,030 Cr | - |
GRANULES INDIA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 17.61 % |
Y-o-Y | 8.30 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹250 Cr | 17.61 | |
Sep2023 | ₹213 Cr | 55.66 | |
Jun2023 | ₹137 Cr | -40.02 | |
Mar2023 | ₹228 Cr | -1.37 | |
Dec2022 | ₹231 Cr | -4.78 | |
Sep2022 | ₹243 Cr | 14.85 | |
Jun2022 | ₹212 Cr | 9.76 | |
Mar2022 | ₹193 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 21.12 % |
Y-o-Y | 7.43 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 21.68% | 21.12 | |
Sep2023 | 17.9% | 28.96 | |
Jun2023 | 13.88% | -27.25 | |
Mar2023 | 19.08% | -5.45 | |
Dec2022 | 20.18% | -4.41 | |
Sep2022 | 21.11% | 1.78 | |
Jun2022 | 20.74% | 10.85 | |
Mar2022 | 18.71% | - |
GRANULES INDIA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 23.05 % |
Y-o-Y | 1.06 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹126 Cr | 23.05 | |
Sep2023 | ₹102 Cr | 113.21 | |
Jun2023 | ₹48 Cr | -59.96 | |
Mar2023 | ₹120 Cr | -3.80 | |
Dec2022 | ₹124 Cr | -14.31 | |
Sep2022 | ₹145 Cr | 13.74 | |
Jun2022 | ₹128 Cr | 14.93 | |
Mar2022 | ₹111 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 26.69 % |
Y-o-Y | 0.18 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 10.87 % | 26.69 | |
Sep2023 | 8.58 % | 76.54 | |
Jun2023 | 4.86 % | -51.40 | |
Mar2023 | 10 % | -7.83 | |
Dec2022 | 10.85 % | -13.96 | |
Sep2022 | 12.61 % | 0.80 | |
Jun2022 | 12.51 % | 16.05 | |
Mar2022 | 10.78 % | - |
GRANULES INDIA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 23.04 % |
Y-o-Y | 0.78 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹5.18 | 23.04 | |
Sep2023 | ₹4.21 | 112.63 | |
Jun2023 | ₹1.98 | -59.92 | |
Mar2023 | ₹4.94 | -3.89 | |
Dec2022 | ₹5.14 | -11.99 | |
Sep2022 | ₹5.84 | 13.62 | |
Jun2022 | ₹5.14 | 14.73 | |
Mar2022 | ₹4.48 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD